相关实验视频
Updated: Feb 17, 2026

05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
1.3K
多学科和以小组为基础的干预措施是改善严重肥胖症患者饮食和健康行为的第一步
Supreet Saluja1,2, Gabrielle Maston Suthern2, Sophia Kwan1,2
1Charles Perkins Centre Nepean, The University of Sydney, Kingwood, Australia.
Nutrition and health
|February 16, 2026
概括
这项研究表明,为期8周的多学科小组干预改善了严重肥胖患者的健康行为和体重结果. 幸福计划降低了体重指数 (BMI) 和改善了情绪,证明了它的有效性.
科学领域:
- 肥胖医学 肥胖医学
- 行为科学 行为科学
- 公共卫生 公共卫生
背景情况:
- 全球严重肥胖症的增加给健康和医疗保健系统带来了重大挑战.
- 多学科,以小组为基础的干预措施有望改善健康行为和体重管理.
- 关于这些干预措施对严重肥胖的疗效的研究有限.
研究的目的:
- 为了评估为期8周的"健康"群体多学科干预措施的有效性.
- 评估严重肥胖患者饮食行为,体重指数 (BMI) 和情绪的初始变化.
- 为了调查澳大利亚新南威尔士州一家公共资助的医院肥胖服务的结果.
主要方法:
- 有127名严重肥胖的人注册参加"健康"干预.
- 第一次会议有98人参加,77人完成了为期8周的课程.
- 在干预前和后评估了饮食摄入量,BMI和情绪 (DASS-21分数) 的变化.
主要成果:
- 观察到BMI,自由选择的食物摄入量以及抑郁和压力得分的显著降低.
- 参与者报告说,他们减少了孤立的感觉,并增强了对健康的理解,而不仅仅是体重.
- 该干预措施对关键健康指标产生了积极的初始影响.
结论:
- 基于小组的多学科干预措施是第三级服务中严重肥胖的有效初步治疗方法.
- 需要进一步的研究来确定参与此类计划的障碍和促进者.
- 作为严重肥胖管理的基本组成部分",Be Well"干预措施显示出希望.
相关概念视频
Binge Eating Disorders
528
Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...
528
Obesity
1.4K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.4K
Acute Coronary Syndrome IV: Interprofessional Care
309
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
309
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
915
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
915
Chronic Pancreatitis II: Collaborative Care
388
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
388
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
301
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
301

